Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
NCT01034865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 750
Last updated 2017-05-01
Summary
To identify risk factors for the development and diagnosis of hepatocellular CA in patients with chronic hepatitis C and to use the data to ultimately develop an effective screening program.
Conditions
- Carcinoma, Hepatocellular
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Mindie H. Nguyen · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-05-31
- Primary Completion
- 2009-06-30
- Completion
- 2009-06-30
Countries
- United States
Study Locations
More Related Trials
-
Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis
NCT03083002 ·Status: UNKNOWN
-
Identification of Liver Fibrosis Biomarkers
NCT06819917 ·Status: RECRUITING
-
Prognostic Models for HCC Based on Tumor Micronecrosis
NCT05837065 ·Status: UNKNOWN
-
Harms of Hepatocellular Carcinoma Surveillance
NCT03756051 ·Status: COMPLETED
-
An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423
NCT01316679 ·Status: COMPLETED
-
The Utility of Breath Biopsy as a Screening Tool for HCC
NCT04326491 ·Status: COMPLETED
-
Detect and Expunge Concealed Tumors of the Liver
NCT06141564 ·Status: ACTIVE_NOT_RECRUITING
-
Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies
NCT05613621 ·Status: ACTIVE_NOT_RECRUITING
-
Retrospective Clinical Validation of HepatoPredict
NCT06894524 ·Status: NOT_YET_RECRUITING
-
Clinical Trial Multi-analyte Blood Test
NCT03694600 ·Status: UNKNOWN
-
Searching for the Liver Cancer-Related Biomarkers
NCT00154544 ·Status: UNKNOWN
-
Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease
NCT01350167 ·Status: UNKNOWN ·Phase: NA
-
Hepatobiliary Tumors Tissue Samples Acquisition
NCT04445532 ·Status: UNKNOWN
-
Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events
NCT01963949 ·Status: WITHDRAWN
-
HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC
NCT03020342 ·Status: UNKNOWN
-
The Surveillance of Hepatocellular Carcinoma
NCT05286099 ·Status: UNKNOWN
-
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study
NCT00629421 ·Status: COMPLETED
-
Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma
NCT00842647 ·Status: UNKNOWN
-
Characteristic and Survival Outcomes in Hepatocellular Carcinoma Patients: on Top of Viral Hepatitis Versus Combined Viral and Metabolic-Associated Steatotic Liver Disease
NCT06871930 ·Status: NOT_YET_RECRUITING
-
The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma
NCT05576571 ·Status: UNKNOWN
-
National Liver Cancer Screening Trial
NCT06084234 ·Status: RECRUITING ·Phase: PHASE4
-
Improving Hepatocellular Carcinoma Screening
NCT05828446 ·Status: RECRUITING ·Phase: NA
-
MSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients with Cirrhosis
NCT06778317 ·Status: NOT_YET_RECRUITING
-
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC
NCT04221347 ·Status: UNKNOWN
-
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
NCT00912847 ·Status: COMPLETED